Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:51:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a phase II study on VRP-HER2 immunizations and pembrolizumab for breast cancer, while adding a new version revision and a mention of the study's location.
    Difference
    44%
    Check dated 2025-04-16T01:42:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 12, 2025. However, the deletion of the date March 25, 2025, indicates a potential change in scheduling or availability.
    Difference
    0.2%
    Check dated 2025-04-08T20:22:53.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The webpage has updated its date references, replacing older dates from 2024 with new dates in 2025, indicating a shift in the timeline for content or events.
    Difference
    0.7%
    Check dated 2025-03-18T04:45:23.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:15:51.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:29:16.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.